TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2019

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer.

Krishnansu S Tewari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.